参考文献/References:
[1] 卢文婷,刘 爽,李赛赛,等.FHL2沉默对骨肉瘤U2OS细胞增殖与凋亡的影响[J].临床肿瘤学杂志,2018,23(1):1-6.
[2] 王海娟,张美芝,刘小菊,等.雷公藤内酯醇逆转肿瘤多药耐药研究进展[J].中国实验方剂学杂志,2016,22(10):229-234.
[3] Ma P,Dong X,Swadley CL,et al.Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia[J].J Biomed Nanotechnol,2009,5(2):151-161.
[4] 张 倩,彭广操,朱明军.雷公藤的药理作用及毒性研究进展[J].中西医结合心脑血管病杂志,2016,(15):1753-1754.
[5] 崔 进,陈 晓,苏佳灿.雷公藤甲素药理作用研究新进展[J].中国中药杂志,2017,42(14):2655-2658.
[6] 蔡灯塔,王新春,王景春.雷公藤甲素联合来氟米特治疗类风湿关节炎的临床效果及对患者血清炎性因子的影响[J].陕西中医,2018,39(9):1260-1262.
[7] 刘 倩,汤建华,张志华.雷公藤甲素对非小细胞肺癌细胞系A549增殖的抑制和凋亡的诱导[J].基础医学与临床,2020,40(3):315-320.
[8] 惠璐璐,许文林,陈巧云,等.雷公藤甲素对K562/A02细胞阿霉素敏感性的影响[J].中国实验血液学杂志,2012,20(1):66-69.
[9] 陈 军,金雪荣,王 翔,等.shRNA干扰COPS3基因对人成骨肉瘤细胞的影响[J].陕西医学杂志,2017,46(3):278-281.
[10] Lourda M,Trougakos IP,Gonos ES.Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on upregulation of clusterin/Apolipoprotein J [J].Int J Cancer,2007,120(3):611-622.
[11] Takara K,Sakaeda T,Okumura K.An update on overcoming MDR-1 mediated multidrug resistance in cancer chemotherapy[J].Curr Pharm Des,2006,12(3):273-286.
[12] 贵 鹏,李朝旭,吴 昊,等.MiRNA靶向调控骨肉瘤耐药机制的研究进展[J].中国肿瘤,2019,28(9):694-698.
[13] Celia M,Freitas G,Heidi VP,et al.Mutidrug resistance mediated by ABC transporters in osteosarcoma cell lines:MRNA ananlysis and functional radiotracer studies[J].Nucl Med Biol,2006,33:831-840.
[14] 袁玉霞,殷佩浩.中药单体逆转MDR1介导的肿瘤多药耐药机制研究进展[J].上海中医药杂志,2017,51(3):96-99.
[15] 汤 涛,董 伟,张 婧,等.中药单体成分逆转肿瘤多药耐药的研究进展[J].中草药,2017,48(4):792-797,846.
[16] 周炳刚,魏昌晟,张 颂,等.苦参碱逆转人乳腺癌MCF-7/ADR细胞株耐药性及对PI3K/AKT信号通路下游因子的影响[J].现代肿瘤医学,2017,25(1):9-13.
[17] Marsousi N,Doffey-Lazeyras F,Rudaz S,et al.Intestinal permeability and P-glycoprotein-mediated efflux transport of ticagrelor in Caco-2 monolayer cells[J].Fundam Clin Pharmacol,2016,30(6):577-584.
[18] 刘风玲,杨 旭.粉防己碱逆转人卵巢癌耐药细胞SKOV3/DDP耐药的逆转作用及机制[J].山东医药,2011,51(45):37-38.
[19] Chen LM,Song TJ,Xiao JH,et al.Tripchlorolide induces autophagy in lung cancer cells by inhibiting the PI3K/AKT/mTOR pathway and improves cisplatin sensitivity in A549/DDP cells[J].Oncotarget,2017,8(38):63911-63922.
[20] Li H,Hui L,Xu W,et al.Modulation of P-glycoprotein expression by triptolide in adriamycin-resistant K562/A02 cells[J].Oncol Lett,2012,3(2):485-489.